SynthesisOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2021

Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials.

D Rosenberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.